Apart from the Chinese car market, things are actually going well at BMW. While arch-rival Mercedes sells fewer and fewer vehicles from month to month, the Munich-based company was able to increase sales by almost nine percent to 588,300 cars in the most recent reporting period. After five declines in a row, it was BMW’s… Continue reading German FAZ: Even BMW can no longer keep up in China010076
Tag: BMW
@BMW: BMW of North America Returns for the 2025 Rebelle Rally in the BMW X5.004403
BMW is back for the nation’s longest competitive offroad challenge. Go to Source
Tesla’s cheaper Model Y faces crowded field in Europe
By Alessandro Parodi (Reuters) –Tesla‘s (TSLA) lower-priced versions of its staple Model Y SUV and Model 3 sedan face an uphill battle in the region where Elon Musk‘s company arguably needs help the most: Europe. Unveiled on Tuesday, the $39,990 Model Y Standard and $36,990 Model 3 will join a European market already crowded with… Continue reading Tesla’s cheaper Model Y faces crowded field in Europe
A Poisonous Halloween for Pets
Not All Toxic Dangers Are Deadly, But They Are All Scary MINNEAPOLIS, Oct. 8, 2025 /PRNewswire/ — Last Halloween, the Ruark family was planning to attend a trunk-or-treat event. Mom Michelle had purchased a large, 90-ounce bag of mini candy bars from Costco, all containing chocolate, and had carefully hidden it inside a shower, behind closed… Continue reading A Poisonous Halloween for Pets
@BMW: PHANTOM AT 100: REFLECTING AND SHAPING THE WORLD THROUGH BESPOKE004402
• Rolls-Royce reflects on 100 years of Bespoke Phantom motor cars• Examines Phantom as both a reflection of, and an influence on, contemporary culture• Traces evolution of commissions in response to social, technological, and cultural change • Underlines Phantom’s enduring ability to enhance and enable its owner’s lifestyle• The ultimate blank… Continue reading @BMW: PHANTOM AT 100: REFLECTING AND SHAPING THE WORLD THROUGH BESPOKE004402
German Handelsblatt: E-mobility: Skoda pushes BMW out of second place for electric cars011567
Tesla celebrates a comeback in the German market in September and further back in the ranking, a Chinese electriciese is pushing on the market with high discounts. Overall, customers can save. Go to source
German Handelsblatt: Auto: Skoda pushes BMW out of second place for electric cars011566
Tesla is celebrating a comeback in the German market in September and further down the ranking, a Chinese electric giant is entering the market with high discounts. Customers can also save more overall. Go to Source
Bidirectional Charging Market worth $844.1 million by 2035 | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 8, 2025 /PRNewswire/ — The global market for bidirectional charging market is projected to grow from USD 70.0 million in 2025 to USD 844.1 million by 2035, at a CAGR of 28.3%, according to a new report by MarketsandMarkets™. The global bidirectional charging market is gaining strong traction, led by the widespread… Continue reading Bidirectional Charging Market worth $844.1 million by 2035 | MarketsandMarkets™
Suzuki Unveils Electric Vehicle Concepts and Multi-Pathway Carbon Strategy at Japan Mobility Show 2025
Suzuki Motor Corporation announced its exhibition lineup for the Japan Mobility Show 2025, showcasing a range of electric vehicle concepts and alternative fuel technologies as part of its comprehensive approach to achieving carbon neutrality. The event, organized by the Japan Automobile Manufacturers Association, will run from October 30 to November 9, 2025, at Tokyo Big… Continue reading Suzuki Unveils Electric Vehicle Concepts and Multi-Pathway Carbon Strategy at Japan Mobility Show 2025
Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD
CTx001 is an investigational AAV-based gene therapy designed to modulate multiple pathways of the complement system Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and preliminary efficacy of CTx001 as a potential one-time treatment for GA Opti-GAIN builds on insights from i-GAIN, a natural history study that has enrolled over 230 participants in… Continue reading Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD